Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Buy
71
MXL Quote, Financials, Valuation and Earnings
Last price:
$20.33
Seasonality move
:
0.14%
Day range:
$19.51 - $21.06
52-week range:
$11.08 - $26.59
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.42x
P/B ratio:
3.18x
Volume:
865.1K
Avg. volume:
1.4M
1-year change:
-15.01%
Market cap:
$1.8B
Revenue:
$693.3M
EPS (TTM):
-$2.73
Analysts' Opinion
-
Consensus RatingMaxLinear has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, MaxLinear has an estimated downside of -4.33% from its current price of $21.01.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $21.01.
Fair Value
-
According to the consensus of 0 analysts, MaxLinear has -4.33% downside to fair value with a price target of -- per share.
MXL vs. S&P 500
-
Over the past 5 trading days, MaxLinear has overperformed the S&P 500 by 6.38% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
MaxLinear does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MaxLinear revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter MaxLinear reported revenues of $81.1M.
Earnings Growth
-
MaxLinear earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter MaxLinear reported earnings per share of -$0.90.
Enterprise value:
1.7B
EV / Invested capital:
2.57x
Price / LTM sales:
4.42x
EV / EBIT:
--
EV / Revenue:
4.44x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-31.24x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$212.1M
Return On Assets:
-22.22%
Net Income Margin (TTM):
-57.37%
Return On Equity:
-35.28%
Return On Invested Capital:
-29.61%
Operating Margin:
-47.69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $1.1B | $858.5M | $393.7M | $135.5M | $81.1M | |
| Gross Profit | $628.2M | $480.5M | $212.1M | $73.9M | $44.1M | |
| Operating Income | $169.5M | $60.2M | -$161.7M | -$17.8M | -$38.7M | |
| EBITDA | $258.1M | $103.4M | -$170.5M | -$21.8M | -$67.7M | |
| Diluted EPS | $1.52 | -$0.04 | -$2.73 | -$0.49 | -$0.90 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $350.1M | $418.3M | $563M | $508.6M | $328.3M | |
| Total Assets | $1B | $1.1B | $1.2B | $1.1B | $895.3M | |
| Current Liabilities | $211.4M | $231.3M | $351.3M | $232.9M | $168.6M | |
| Total Liabilities | $611M | $596.4M | $566.8M | $401.1M | $338.4M | |
| Total Equity | $396.8M | $457.5M | $615.9M | $702.7M | $556.9M | |
| Total Debt | $380.2M | $326M | $171.6M | $122.2M | $122.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $335.4M | $129.3M | -$34M | -$12.8M | -$30.7M | |
| Cash From Investing | -$92.6M | -$48.1M | -$5.6M | -$2.6M | -$6M | |
| Cash From Financing | -$226.8M | -$76.1M | $1M | -$21.5M | -$58K | |
| Free Cash Flow | $287.1M | $93.6M | -$55.9M | -$15.4M | -$36.7M | |
MXL
Sector
Market Cap
$1.8B
$126.1M
Price % of 52-Week High
79.02%
69.28%
Dividend Yield
0%
0%
Shareholder Yield
-0.26%
1%
1-Year Price Total Return
-15.01%
-7.01%
Beta (5-Year)
1.874
0.944
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$19.90
200-day SMA
Buy
Level
$17.22
Bollinger Bands (100)
Buy
Level
12.42 - 17.22
Chaikin Money Flow
Buy
Level
79.1M
20-day SMA
Buy
Level
$18.80
Relative Strength Index (RSI14)
Buy
Level
66.67
ADX Line
Buy
Level
17.09
Williams %R
Sell
Level
-18.9189
50-day SMA
Buy
Level
$16.33
MACD (12, 26)
Buy
Level
1.21
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
98.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.583)
Buy
CA Score
(Annual)
Level (0.0359)
Buy
Beneish M-Score
(Annual)
Level (-2.6979)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.7856)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. MaxLinear's product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices. Customers for MaxLinear include original equipment manufacturers, module makers, and original design manufacturers.
Stock Forecast FAQ
In the current month, MXL has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MXL average analyst price target in the past 3 months is --.
-
Where Will MaxLinear Stock Be In 1 Year?
According to analysts, the consensus estimate is that MaxLinear share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About MaxLinear?
Analysts are divided on their view about MaxLinear share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MaxLinear is a Sell and believe this share price will rise from its current level to --.
-
What Is MaxLinear's Price Target?
The price target for MaxLinear over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MXL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MaxLinear is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of MXL?
You can purchase shares of MaxLinear via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MaxLinear shares.
-
What Is The MaxLinear Share Price Today?
MaxLinear was last trading at $20.33 per share. This represents the most recent stock quote for MaxLinear. Yesterday, MaxLinear closed at $21.01 per share.
-
How To Buy MaxLinear Stock Online?
In order to purchase MaxLinear stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.26% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 5.3% over the past day.
